Helix BioPharma Ratios and Metrics

Market cap in millions USD. Fiscal year is August - July.

Millions USD. Fiscal year is Aug - Jul.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '25 Oct 21, 2025	Jul '25 Jul 31, 2025	Jul '24 Jul 31, 2024	Jul '23 Jul 31, 2023	Jul '22 Jul 31, 2022	Jul '21 Jul 31, 2021
Market Capitalization	102	57	41	32	25	94
Market Cap Growth	182.14%	40.48%	27.81%	25.38%	-72.89%	75.26%
Enterprise Value	102	57	40	31	26	92
Last Close Price	1.73	0.60	0.83	0.72	0.77	3.58
PB Ratio	8.91	5.09	-626.39	-49.71	102.32	-84.09
P/TBV Ratio	-	-	-	-	102.32	-
Debt / Equity Ratio	0.02	0.02	-	-	7.74	-2.59
Quick Ratio	0.18	0.06	0.72	0.46	1.03	1.01
Current Ratio	0.23	0.13	0.92	0.53	1.08	1.04
Return on Equity (ROE)	-66.34%	-67.18%	-	-	-	-1205.79%
Return on Assets (ROA)	-30.36%	-33.25%	-458.65%	-166.12%	-96.84%	-127.23%
Return on Capital Employed (ROCE)	-29.40%	-34.60%	10265.60%	748.60%	-1887.50%	-4780.60%
Earnings Yield	-3.41%	-6.56%	-16.43%	-14.97%	-20.11%	-6.86%
FCF Yield	-2.93%	-4.83%	-9.28%	-13.18%	-19.94%	-7.94%
Buyback Yield / Dilution	-35.46%	-25.29%	-15.11%	-29.26%	-8.41%	-7.97%

Updated Oct 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.